Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C21H23FN4O2 |
| Molecular Weight | 382.4313 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)(C)[C@H](NC(=O)C1=NN(CC2=CC=C(F)C=C2)C3=CC=CC=C13)C(N)=O
InChI
InChIKey=ZSSGCSINPVBLQD-GOSISDBHSA-N
InChI=1S/C21H23FN4O2/c1-21(2,3)18(19(23)27)24-20(28)17-15-6-4-5-7-16(15)26(25-17)12-13-8-10-14(22)11-9-13/h4-11,18H,12H2,1-3H3,(H2,23,27)(H,24,28)/t18-/m1/s1
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide [ADB-FUBINACA] is a synthetic cannabinoid, a Schedule I drug. ADB-FUBINACA acts as a high potency agonist of cannabinoid CB1 receptor. The compound considered to be a component of illicit smoking mixtures "spice".
Originator
Sources: https://www.google.com/patents/WO2009106982A1 | https://www.ncbi.nlm.nih.gov/pubmed/26134475
Curator's Comment: # Pfizer
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| UPLC/ESI-MS/MS-based determination of metabolism of several new illicit drugs, ADB-FUBINACA, AB-FUBINACA, AB-PINACA, QUPIC, 5F-QUPIC and α-PVT, by human liver microsome. | 2014 Jun |
|
| Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA. | 2015 Sep 16 |
|
| Death Associated With the Use of the Synthetic Cannabinoid ADB-FUBINACA. | 2016 Apr |
|
| Schedules of Controlled Substances: Temporary Placement of Six Synthetic Cannabinoids (5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA) into Schedule I. Temporary Scheduling Order. | 2017 Apr 10 |
|
| Supraventricular tachycardia and acute confusion following ingestion of e-cigarette fluid containing AB-FUBINACA and ADB-FUBINACA: a case report with quantitative analysis of serum drug concentrations. | 2017 Aug |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-ADB-FUBINACA
Created by
admin on Sat Dec 16 10:40:23 GMT 2023 , Edited by admin on Sat Dec 16 10:40:23 GMT 2023
|
||
|
DEA NO. |
7010
Created by
admin on Sat Dec 16 10:40:23 GMT 2023 , Edited by admin on Sat Dec 16 10:40:23 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
58124399
Created by
admin on Sat Dec 16 10:40:23 GMT 2023 , Edited by admin on Sat Dec 16 10:40:23 GMT 2023
|
PRIMARY | |||
|
05235E1S2O
Created by
admin on Sat Dec 16 10:40:23 GMT 2023 , Edited by admin on Sat Dec 16 10:40:23 GMT 2023
|
PRIMARY | |||
|
ADB-FUBINACA
Created by
admin on Sat Dec 16 10:40:23 GMT 2023 , Edited by admin on Sat Dec 16 10:40:23 GMT 2023
|
PRIMARY | |||
|
DTXSID70100998
Created by
admin on Sat Dec 16 10:40:23 GMT 2023 , Edited by admin on Sat Dec 16 10:40:23 GMT 2023
|
PRIMARY | |||
|
1445583-51-6
Created by
admin on Sat Dec 16 10:40:23 GMT 2023 , Edited by admin on Sat Dec 16 10:40:23 GMT 2023
|
NON-SPECIFIC STEREOCHEMISTRY | |||
|
100000183998
Created by
admin on Sat Dec 16 10:40:23 GMT 2023 , Edited by admin on Sat Dec 16 10:40:23 GMT 2023
|
PRIMARY | |||
|
1185282-00-1
Created by
admin on Sat Dec 16 10:40:23 GMT 2023 , Edited by admin on Sat Dec 16 10:40:23 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
METABOLITE (PARENT)
METABOLITE (PARENT)
